MAX
Company Analysis Amexdrug Corporation
1. Summary
Advantages
- Price (0.0002 $) is less than fair price (0.0012 $)
- Current debt level 18.64% is below 100% and has decreased over 5 years from 53.27%.
Disadvantages
- Dividends (0%) are below the sector average (592.52%).
- The stock's return over the last year (-90%) is lower than the sector average (-6.15%).
- The company's current efficiency (ROE=0.65%) is lower than the sector average (ROE=9.99%)
Similar companies
2. Share price and performance
2.1. Share price
2.3. Market efficiency
| Amexdrug Corporation | Index | ||
|---|---|---|---|
| 7 days | 0% | -0.6% | -0.6% |
| 90 days | 0% | 0.3% | 2.7% |
| 1 year | -90% | -6.1% | 12.7% |
AXRX vs Sector: Amexdrug Corporation has significantly underperformed the "" sector by -83.85% over the past year.
AXRX vs Market: Amexdrug Corporation has significantly underperformed the market by -102.7% over the past year.
Stable price: AXRX is not significantly more volatile than the rest of the market on "USA Stocks" over the last 3 months, with typical variations of +/- 5% per week.
Long period: AXRX with weekly volatility of -1.73% over the past year.
3. Summary of the report
5. Fundamental Analysis
5.1. Stock price and price forecast
Below fair price: The current price (0.0002 $) is lower than the fair price (0.0012 $).
Price significantly below the fair price: The current price (0.0002 $) is 500% lower than the fair price.
5.2. P/E
P/E vs Sector: The company's P/E (29.63) is lower than that of the sector as a whole (231.08).
P/E vs Market: The company's P/E (29.63) is lower than that of the market as a whole (139.92).
5.2.1 P/E Similar companies
5.3. P/BV
P/BV vs Sector: The company's P/BV (0.19) is lower than that of the sector as a whole (3.54).
P/BV vs Market: The company's P/BV (0.19) is lower than that of the market as a whole (2.9).
5.3.1 P/BV Similar companies
5.5. P/S
P/S vs Sector: The company's P/S indicator (0.0997) is lower than that of the sector as a whole (12.89).
P/S vs Market: The company's P/S indicator (0.0997) is lower than that of the market as a whole (5.38).
5.5.1 P/S Similar companies
5.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (6.05) is lower than that of the sector as a whole (11.15).
EV/Ebitda vs Market: The company's EV/Ebitda (6.05) is lower than that of the market as a whole (12.33).
6. Profitability
6.1. Profitability and revenue
6.2. Earnings per share - EPS
6.3. Past profitability Net Income
Yield Trend: Negative and has fallen by -16.92% over the last 5 years.
Accelerating profitability: The return for the last year (0%) exceeds the average return for 5 years (-16.92%).
Profitability vs Sector: The return for the last year (0%) is lower than the return for the sector (0%).
6.4. ROE
ROE vs Sector: The company's ROE (0.65%) is lower than that of the sector as a whole (9.99%).
ROE vs Market: The company's ROE (0.65%) is lower than that of the market as a whole (187.53%).
6.6. ROA
ROA vs Sector: The company's ROA (0.46%) is higher than that of the sector as a whole (0.43%).
ROA vs Market: The company's ROA (0.46%) is lower than that of the market as a whole (170.29%).
6.6. ROIC
ROIC vs Sector: The company's ROIC (0%) is lower than that of the sector as a whole (0%).
ROIC vs Market: The company's ROIC (0%) is lower than that of the market as a whole (8.35%).
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
8. Dividends
8.1. Dividend yield vs Market
Low yield: The dividend yield of the company 0% is below the average for the sector '592.52%.
8.2. Stability and increase in payments
Unstable dividends: The company's dividend yield 0% has not been consistently paid over the past 7 years, DSI=0.
Weak dividend growth: The company's dividend yield 0% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.
8.3. Payout percentage
Dividend Coverage: Current payments from income (0%) are at an uncomfortable level.
Based on sources: porti.ru
